re: Ann: FDA agrees on potential regulatory p... Not sure if I have missed something but what is the status with the current (t315i mutation) nda? Both commentary and graph seem to indicate nothing - have FDA given any indication of what needs to be done with that to get approval? Or is it a dead duck and all the focus is now on multi tki avenue.
Any thoughts appreciated.
Ann: FDA agrees on potential regulatory pathway f, page-7
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)